These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9829811)

  • 61. Utrophin localization in normal and dystrophin-deficient heart.
    Pons F; Robert A; Fabbrizio E; Hugon G; Califano JC; Fehrentz JA; Martinez J; Mornet D
    Circulation; 1994 Jul; 90(1):369-74. PubMed ID: 8026021
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Relationship between utrophin and regenerating muscle fibers in duchenne muscular dystrophy.
    Shim JY; Kim TS
    Yonsei Med J; 2003 Feb; 44(1):15-23. PubMed ID: 12619170
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dystrophin immunostaining of muscle from Chinese patients with various neuromuscular diseases.
    Jong YJ; Chuang YH; Chen SS; Chen BH; Chiang CH
    J Formos Med Assoc; 1991 Dec; 90(12):1143-8. PubMed ID: 1686882
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expression of utrophin and its mRNA in denervated mdx mouse muscle.
    Jasmin BJ; Alameddine H; Lunde JA; Stetzkowski-Marden F; Collin H; Tinsley JM; Davies KE; Tomé FM; Parry DJ; Cartaud J
    FEBS Lett; 1995 Nov; 374(3):393-8. PubMed ID: 7589578
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses.
    Côté PD; Moukhles H; Lindenbaum M; Carbonetto S
    Nat Genet; 1999 Nov; 23(3):338-42. PubMed ID: 10610181
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Utrophin abundance is reduced at neuromuscular junctions of patients with both inherited and acquired acetylcholine receptor deficiencies.
    Slater CR; Young C; Wood SJ; Bewick GS; Anderson LV; Baxter P; Fawcett PR; Roberts M; Jacobson L; Kuks J; Vincent A; Newsom-Davis J
    Brain; 1997 Sep; 120 ( Pt 9)():1513-31. PubMed ID: 9313636
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy.
    Nicholson LV; Johnson MA; Gardner-Medwin D; Bhattacharya S; Harris JB
    Acta Neuropathol; 1990; 80(3):239-50. PubMed ID: 2205076
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Eye muscle sparing by the muscular dystrophies: lessons to be learned?
    Andrade FH; Porter JD; Kaminski HJ
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):192-203. PubMed ID: 10679966
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dystrophin expression in skin biopsy immunohistochemical. Localisation of striated muscle type dystrophin.
    Marbini A; Marcello N; Bellanova MF; Guidetti D; Ferrari A; Gemignani F
    J Neurol Sci; 1995 Mar; 129(1):29-33. PubMed ID: 7751841
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy.
    Chao DS; Gorospe JR; Brenman JE; Rafael JA; Peters MF; Froehner SC; Hoffman EP; Chamberlain JS; Bredt DS
    J Exp Med; 1996 Aug; 184(2):609-18. PubMed ID: 8760814
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Altered muscle saccharide pattern in X-linked muscular dystrophy.
    Paljärvi L; Karjalainen K; Kalimo H
    Arch Neurol; 1984 Jan; 41(1):39-42. PubMed ID: 6689886
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterisation of the dystrophin-related protein utrophin in highly purified skeletal muscle sarcolemma vesicles.
    Ohlendieck K
    Biochim Biophys Acta; 1996 Sep; 1283(2):215-22. PubMed ID: 8809102
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Full-length and short forms of utrophin, the dystrophin-related protein.
    Nguyen TM; Helliwell TR; Simmons C; Winder SJ; Kendrick-Jones J; Davies KE; Morris GE
    FEBS Lett; 1995 Jan; 358(3):262-6. PubMed ID: 7843413
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Muscle membrane-skeleton protein changes and histopathological characterization of muscle-eye-brain disease.
    Auranen M; Rapola J; Pihko H; Haltia M; Leivo I; Soinila S; Virtanen I; Kalimo H; Anderson LV; Santavuori P; Somer H
    Neuromuscul Disord; 2000 Jan; 10(1):16-23. PubMed ID: 10677859
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Regeneration in sarcoglycanopathies: expression studies of sarcoglycans and other muscle proteins.
    Fanin M; Angelini C
    J Neurol Sci; 1999 Jun; 165(2):170-7. PubMed ID: 10450803
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Congenital myopathy associated with abnormal accumulation of desmin and dystrophin.
    Prelle A; Moggio M; Comi GP; Gallanti A; Checcarelli N; Bresolin N; Ciscato P; Fortunato F; Scarlato G
    Neuromuscul Disord; 1992; 2(3):169-75. PubMed ID: 1483042
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunohistochemical study of utrophin and dystrophin at the motor end-plate in myasthenia gravis.
    Ito H; Yoshimura T; Satoh A; Takino H; Tsujihata M; Nagataki S
    Acta Neuropathol; 1996 Jul; 92(1):14-8. PubMed ID: 8811120
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cytoplasmic body myopathy: familial cases with accumulation of desmin and dystrophin. An immunohistochemical, immunoelectron microscopic and biochemical study.
    Caron A; Viader F; Lechevalier B; Chapon F
    Acta Neuropathol; 1995; 90(2):150-7. PubMed ID: 7484090
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Supramolecular organization of the subsarcolemmal cytoskeleton of adult skeletal muscle fibers. A review.
    Berthier C; Blaineau S
    Biol Cell; 1997 Oct; 89(7):413-34. PubMed ID: 9561721
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Loss of sarcolemmal nNOS is common in acquired and inherited neuromuscular disorders.
    Finanger Hedderick EL; Simmers JL; Soleimani A; Andres-Mateos E; Marx R; Files DC; King L; Crawford TO; Corse AM; Cohn RD
    Neurology; 2011 Mar; 76(11):960-7. PubMed ID: 21403107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.